Parexel to work with Singapore on clinical research training
pharmafile | October 11, 2011 | News story | Research and Development | Asia, CRO, Parexel, Singapore, clinical research
Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in clinical research.
The pharma industry and contract research organisations like Parexel are rapidly expanding the number of clinical trials being conducted in Asia, along with investment in drug discovery.
But the sector’s demand for scientists trained to oversee clinical research far exceeds the supply in the region.
Parexel has its own training academy, and has now created an academic course dedicated to training Asia’s scientists to work in the field.
The company has teamed up with the National University of Singapore Academy of GxP Excellence (NUSAGE) to deliver what it says will be a world-class academic programme focused on global best practices and latest industry advances.
Dr. Albert Siu, Vice President, Learning and Development, Parexel International said: “The Academy’s location in Singapore provides students with access to a significant business centre for the Asia/Pacific region, and supports regional growth in the clinical development field. These graduates will be empowered with the proper education to make a difference in the delivery of innovative new treatments to patients.”
Dr. Siu said Singapore university would also provide distinctive expertise and insights related to Asia.
“NUSAGE is pleased to partner with Parexel in this timely initiative to equip clinical development professionals with critical skills to effectively and efficiently translate research from the laboratory into clinical studies, and ultimately to bring significant life-saving treatments to patients in Asia and around the world,” said Associate Professor Chan Sui Yung, Head of the Department of Pharmacy, NUS.
“For biomedical sciences companies looking to succeed in the rapidly-emerging Asian biopharmaceutical industry, Singapore offers a vantage point in Asia from which they can develop the requisite international and multi-disciplinary talent to support their growth. The establishment of the first Parexel Academy in Asia, in Singapore, underscores the importance of developing talent in a diverse Asian clinical environment,” said Mr. Kevin Lai, Deputy Director Biomedical Sciences, Singapore Economic Development Board.
Parexel Academy is based in Berlin and has offered professional training and education since 2001. It provides postgraduate courses for clinical research associates, study nurses, and study co-ordinators. Training courses are also provided for investigators with special emphasis on conducting clinical trials in accordance with International Conference on Harmonization-Good Clinical Practice (ICH-GCP) standards.
Andrew McConaghie
Related Content
Crown Bioscience opens new US model development centre
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …
From molecule to market and beyond: Uniphar announces extended global commercialization platform
22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service …
AbbVie invests $223m in Singapore manufacturing site
AbbVie has announced that it has invested $223m in an expansion to its Singapore manufacturing …
